Ashraf Azzabi

1.2k total citations
13 papers, 208 citations indexed

About

Ashraf Azzabi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ashraf Azzabi has authored 13 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ashraf Azzabi's work include Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Ashraf Azzabi is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Ashraf Azzabi collaborates with scholars based in United Kingdom, Canada and Tunisia. Ashraf Azzabi's co-authors include Alan V. Boddy, Paula Calvert, Ruth Plummer, Rob Johnson, Mark Verrill, Martin Griffin, Hilary Calvert, David R. Newell, A. Hilary Calvert and Michael A. Batey and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Ashraf Azzabi

11 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf Azzabi United Kingdom 5 140 62 27 23 20 13 208
Martha Perisoglou United Kingdom 3 69 0.5× 49 0.8× 34 1.3× 28 1.2× 6 0.3× 6 150
Dawn Dolan United States 6 31 0.2× 128 2.1× 32 1.2× 18 0.8× 13 0.7× 7 199
Laura Rodríguez Spain 7 57 0.4× 125 2.0× 41 1.5× 8 0.3× 15 0.8× 27 186
Paola Di Nardo Italy 6 114 0.8× 104 1.7× 30 1.1× 3 0.1× 16 0.8× 17 208
Koichiro Nozaki Japan 9 72 0.5× 133 2.1× 54 2.0× 10 0.4× 7 0.3× 16 237
Luisa Piccin Italy 5 69 0.5× 167 2.7× 30 1.1× 5 0.2× 31 1.6× 16 219
Julia Dudnik Israel 9 89 0.6× 86 1.4× 32 1.2× 4 0.2× 8 0.4× 23 143
Haocan Song United States 7 74 0.5× 124 2.0× 48 1.8× 5 0.2× 11 0.6× 10 233
Fiorella Ruatta Italy 7 101 0.7× 123 2.0× 31 1.1× 4 0.2× 25 1.3× 26 200
Barbara Sosnowska‐Pasiarska Poland 8 36 0.3× 94 1.5× 22 0.8× 5 0.2× 16 0.8× 18 201

Countries citing papers authored by Ashraf Azzabi

Since Specialization
Citations

This map shows the geographic impact of Ashraf Azzabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Azzabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Azzabi more than expected).

Fields of papers citing papers by Ashraf Azzabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Azzabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Azzabi. The network helps show where Ashraf Azzabi may publish in the future.

Co-authorship network of co-authors of Ashraf Azzabi

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Azzabi. A scholar is included among the top collaborators of Ashraf Azzabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Azzabi. Ashraf Azzabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Azzabi, Ashraf, et al.. (2022). POS-785 A Case of Drug-Induced Intracranial Hypertension due to Mycophenolate Mofetil use following renal transplantation. Kidney International Reports. 7(2). S338–S338.
2.
Jiang, Xue, R. Pearson, Darren Leaning, et al.. (2020). Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life. Clinical Oncology. 32(10). e177–e187. 13 indexed citations
3.
Jiang, Xue, Alexander Burns, J. Frew, et al.. (2019). Radium 223 treatment in metastatic castrate-resistant prostate cancer: Impact of sequencing on survival—Real-world outcomes from a single United Kingdom center.. Journal of Clinical Oncology. 37(7_suppl). 223–223. 2 indexed citations
4.
5.
Pieniążek, Piotr, Rakesh Heer, R. McMenemin, et al.. (2016). Evaluation of early response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using dynamic contrast-enhanced MRI and diffusion weighted MRI: MARBLE study.. Journal of Clinical Oncology. 34(2_suppl). 403–403. 2 indexed citations
6.
Rajan, Prabhakar, J. Frew, James M. Wilson, et al.. (2015). Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non–castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 33(8). 337.e1–337.e6. 4 indexed citations
7.
Iqbal, Muhammad Shahid, Ian Pedley, J. Frew, et al.. (2014). Delays in the diagnosis and treatment of muscle invasive bladder cancer: A pilot project mapping the pathway. Journal of Clinical Urology. 8(4). 246–251. 2 indexed citations
8.
9.
Pedley, Ian, et al.. (2012). U.K. experience of sunitinib malate in the treatment of metastatic renal cell carcinoma: Predictors of response from clinical practice.. Journal of Clinical Oncology. 30(5_suppl). 455–455. 1 indexed citations
10.
11.
Azzabi, Ashraf, E. Ruth Plummer, Melanie Griffin, et al.. (2005). Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. British Journal of Cancer. 92(6). 1006–1012. 19 indexed citations
12.
Batey, Michael A., et al.. (2002). Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). European Journal of Cancer. 38(8). 1081–1089. 36 indexed citations
13.
Calvert, Paula, Ashraf Azzabi, Ruth Plummer, et al.. (2002). Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma. Journal of Clinical Oncology. 20(16). 3533–3544. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martha Perisoglou Breakdown of academic impact, for papers by Dawn Dolan Breakdown of academic impact, for papers by Laura Rodríguez Breakdown of academic impact, for papers by Paola Di Nardo Breakdown of academic impact, for papers by Koichiro Nozaki Breakdown of academic impact, for papers by Luisa Piccin Breakdown of academic impact, for papers by Julia Dudnik Breakdown of academic impact, for papers by Haocan Song Breakdown of academic impact, for papers by Fiorella Ruatta Breakdown of academic impact, for papers by Barbara Sosnowska‐Pasiarska
Rankless by CCL
2026